Altaris Closes Sale of BK Medical
New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the sale of BK Medical to General Electric Company (NYSE: GE) for a cash purchase price of $1.45 billion.
Headquartered in Boston and Copenhagen, BK Medical is a global intraoperative imaging and surgical navigation company. Through advanced ultrasound technology and sophisticated software algorithms, BK Medical enables surgeons to make real-time, data-based decisions during surgical procedures, resulting in better clinical outcomes and reduced costs for patients, physicians, and the healthcare system. BK Medical has a global installed base of more than 14,000 advanced imaging platforms and its proprietary technology is protected with more than 136 patent families.
J.P. Morgan Securities LLC served as lead financial advisor, Morgan Stanley & Co. LLC served as financial advisor, and Latham & Watkins LLP and Schiff Hardin LLP acted as legal counsel to BK Medical.
Altaris is a healthcare investment firm with an exclusive focus on building companies that deliver value to the healthcare system through innovation and efficiency. Altaris’ operating companies are addressing some of the most complex problems in the healthcare industry, with the ultimate goal of improving access and outcomes for patients. Since inception in 2003, Altaris has invested in more than 45 healthcare companies that have contributed to advancements in the industry and generated significant value appreciation for investors. Altaris is headquartered in New York City and manages $6.0 billion of equity capital. For more information, visit www.altariscap.com.